PDCD1 and laryngotracheoesophageal cleft: Thus, the nomogram derived from prospectively collected data on 125 LC patients, composed of the lung metastasis and blood biomarkers in baseline, could be used to a more convenient biomarker for the prediction of OS and treatment strategy guidance for lung patients with PD-1/PD-L1 inhibitor therapy.